Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      The next person to shop your store may not be a person at all

      AI shopping agents are rewriting the rules of online retail across North America

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Cohere's Aidan Gomez bets the house on 'sovereign AI' with Aleph Alpha merger valuing the group at $20bn

      Cohere CEO Aidan Gomez on stage discussing the Toronto AI lab's strategy

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Moonvalley's Naeem Talukdar is selling Hollywood the one thing rival AI video tools cannot: legal cover

      Moonvalley's Marey AI video model produces Hollywood-grade footage trained on licensed data

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
Sunday 29 August 2021 2:17 pm  |  Updated:  Friday 05 November 2021 12:48 pm

Doctors face difficult choices as blood tests rationed

By: Emily Hawkins

Add as a preferred source on Google
Despite reporting a challenging year, shares in the AIM-listed Fusion Antibodies sprung up 7.5 per cent at market open on Thursday.
Despite reporting a challenging year, shares in the AIM-listed Fusion Antibodies sprung up 7.5 per cent at market open on Thursday.

GPs have called for more clarity over how long a shortage of blood test tubes will last as they face tough choices.

Doctors have been forced to stop all non-urgent testing after a shortage of vials, caused by Covid demands and transport issues.

The NHS in England and Wales has told doctors to temporarily halt some tests  including those for fertility, allergies and pre-diabetes.

Supplier Becton Dickinson said it has experienced record demand for tubes over recent months, in part due to Covid patients.

The supplier has also been affected by transport issues including challenges at the UK border.

The shortage is likely to worsen over the next few weeks and could last until mid-September, NHS England said.

The government is working with suppliers while the NHS looks for alternative products.

“No doctor knowingly undertakes unnecessary blood tests and to now have to ration all those we are doing, as well as cancel hundreds more, goes against everything we stand for as clinicians,” the British Medical Association’s Dr David Wrigley said.

Read more

Jet fuel crisis worse than Covid for airlines, says AirAsia chief

EasyJet aircraft touching down on runway amid clear skies, highlighting travel industry updates and aviation business trends.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Trending Articles

  • As it happened: FTSE 100 relief rally runs out of steam as BP and Shell weigh; Oil hits three-month low

  • London Tech Week sums up everything wrong with UK tech

  • Rolls-Royce shares surge as SMR unit bags multi-billion pound Swedish nuclear contract

  • KPMG’s Summer Friday half-day rollback signals deeper woes for Big Four giants

  • Inflation expectations at record high in interest rates signal

More from CityAM

  • ZayZoon, the Calgary fintech born on a fishing boat, posts 1,487% growth as earned wage access goes mainstream

    ZayZoon co-founder Tate Hackert built the Calgary fintech around earned wage access
  • Life after Starmer: What could a new Labour prime minister mean for your money?

    Personal Finance
    Andy Burnham speaking at a Labour Party event, addressing current political issues, with a focused and determined expression.
  • Botpress raises $25m as Quebec's Sylvain Perron pitches his startup as the 'infrastructure layer' for AI agents

    Botpress product UI: the Quebec startup pitches itself as the infrastructure layer for enterprise AI agents
  • FluidAI wins US FDA clearance for its surgical monitor as Waterloo's Youssef Helwa targets 100,000 operations

    FluidAI's Origin surgical monitor wins FDA clearance for use in US hospitals
  • Award winning Medtech firm excels again

    Partner
    Unable to generate alt text without specific article content or context. Please provide more details or context.
  • Semble Secures £30M Series C Investment Led by Revaia to Expand Europe’s Connected Healthcare Platform

    Business Wire
  • Heathrow passenger volumes drop as jet fuel crisis rocks market

    Transport & Infrastructure
    Aerial view of Heathrow Airports bustling terminals with parked airplanes and surrounding infrastructure
  • IAG: British Airways owner plays down jet fuel shortage concerns

    Aviation
    A British Airways plane taxis from Heathrow's Terminal 5
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
Copyright 2026 CityAM Limited